| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 03/29/2007 | US20070072810 Agent for treating diabetes |
| 03/29/2007 | CA2623462A1 Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them |
| 03/28/2007 | EP1767525A1 Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists |
| 03/28/2007 | EP1765783A1 Separation of fluorous compounds |
| 03/28/2007 | EP1765777A2 Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors |
| 03/27/2007 | US7196088 5-HT6 modulators; such as 2-benzenesulfonyl-5-piperazin-1-yl-1,2,3,4-tetrahydroisoquinoline; |
| 03/22/2007 | WO2006105127A3 Hydroxysteroid dehydrogenase inhibitors |
| 03/22/2007 | US20070066664 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses, materials for their synthesis |
| 03/22/2007 | US20070066623 Entry inhibitors of the hiv virus |
| 03/22/2007 | US20070066600 Compounds |
| 03/22/2007 | US20070066599 New compounds |
| 03/22/2007 | US20070066598 Compounds |
| 03/22/2007 | US20070066586 Aniline derivatives |
| 03/22/2007 | DE102005044817A1 Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament Substituted 4-Phenyltetrahydroisochinoline, processes for their preparation, their use as a medicament, and medicament containing them |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1763516A2 Substituted tetrahydroisochinolines used in the form of mmp inhibitors, method for the production and use thereof in the form of drags |
| 03/21/2007 | EP1763515A1 4-trifluoromethoxyphenoxybenzol-4'-sulfonic acids, method for the production and use thereof in medicaments |
| 03/21/2007 | EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 03/21/2007 | CN1934104A Compounds for the treatment of diseases |
| 03/21/2007 | CN1933839A Compounds and methods of use |
| 03/21/2007 | CN1305854C Intermediates for making HIV-protease inhibitors and method for making HIV-protease inhibitors |
| 03/21/2007 | CN1305852C Diaryl ethers as opioid receptor antagonist |
| 03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/20/2007 | US7193065 activated haptens useful for generating immunogens to HIV protease inhibitors |
| 03/20/2007 | US7192982 Modulators of peroxisome proliferator activated receptors |
| 03/15/2007 | WO2007029107A1 Isoquinolines derivatives as igf-1r inhibitors |
| 03/15/2007 | WO2007029106A1 Isoquinolines as igf-1r inhibitors |
| 03/15/2007 | US20070060757 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms |
| 03/15/2007 | US20070060582 1,4-Disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases |
| 03/15/2007 | CA2621836A1 Isoquinolines as igf-1r inhibitors |
| 03/15/2007 | CA2621820A1 Isoquinolines derivatives as igf-1r inhibitors |
| 03/14/2007 | EP1761497A2 Azadecalin glucocorticoid receptor modulators |
| 03/14/2007 | EP1511728B1 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 03/14/2007 | EP1045837B1 Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof |
| 03/14/2007 | CN1930139A Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 03/13/2007 | US7189864 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors |
| 03/13/2007 | US7189730 A2A adenosine receptor antagonists |
| 03/13/2007 | US7189728 Inhibitors of dipeptidyl peptidase IV |
| 03/13/2007 | US7189727 Guanidino compounds |
| 03/08/2007 | WO2007025709A2 Organic compounds |
| 03/08/2007 | US20070054909 VLA-4 inhibitor compounds |
| 03/08/2007 | US20070054892 Isoquinoline potassium channel inhibitors |
| 03/08/2007 | US20070054888 Novel substituted diamine derivatives useful as motilin agonists |
| 03/08/2007 | CA2620222A1 Organic compounds |
| 03/07/2007 | EP1758908A1 Extraction of alkaloids from opium |
| 03/07/2007 | EP1758884A2 N-cyclic sulfonamido inhibitors of gamma secretase |
| 03/07/2007 | EP1758864A1 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments |
| 03/07/2007 | EP1758861A1 Dpp-iv inhibitors |
| 03/07/2007 | EP1758847A1 Inhibitors of histone deacetylase |
| 03/07/2007 | CN1926109A Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
| 03/07/2007 | CN1926097A Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 03/07/2007 | CN1303074C Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 03/07/2007 | CN1303069C Acutumine and acutumine compound, synthesis and use thereof |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/06/2007 | US7186725 Anti-inflammatory compositions and methods |
| 03/06/2007 | US7186719 Antibacterial agents |
| 03/06/2007 | US7186715 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 03/06/2007 | CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/01/2007 | WO2006020049A8 Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 03/01/2007 | WO2005117876A8 Dual small molecule inhibitors of cancer and angiogenesis |
| 03/01/2007 | US20070048286 Method of treating dopaminergic and GABA-nergic disorders |
| 02/28/2007 | EP1757584A1 Heterocyclic substituted amides, their production and their use |
| 02/28/2007 | EP1756101A2 Androgen receptor modulators and method of treating disease using the same |
| 02/28/2007 | EP1756063A1 Amido compounds and their use as pharmaceuticals |
| 02/28/2007 | EP1756058A1 Histamine-3 receptor antagonists |
| 02/28/2007 | EP1756044A1 Therapeutic compounds |
| 02/28/2007 | EP1755593A1 Naphthaline derivatives useful as histamine-3-receptor ligands |
| 02/28/2007 | EP1492771B1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 02/28/2007 | EP1456209B1 A2a adenosine receptor antagonists |
| 02/28/2007 | EP1397350B1 Isoquinolinone derivatives as parp inhibitors |
| 02/28/2007 | EP1240154B1 Serine protease inhibitors |
| 02/28/2007 | CN1922147A Novel style heterocyclic compound as insulin-like growth factors first type acceptor inhibitor |
| 02/28/2007 | CN1922138A Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 02/27/2007 | US7183411 Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptor |
| 02/22/2007 | WO2007020046A1 Benzoquinazoline derivatives and their use in treating bone disorders |
| 02/22/2007 | WO2005089511A3 Novel pharmaceutical forms, and methods of making and using the same |
| 02/22/2007 | US20070043040 Inhibitors of akt (protein kinase b) |
| 02/22/2007 | US20070043026 Dopamine receptor modulators as antipsychotic agents |
| 02/22/2007 | US20070042996 N-alkynyl-2-(substituted aryloxy) alkylthioamine derivatives as fungicides |
| 02/22/2007 | CA2619249A1 Benzoquinazoline derivatives and their use in treating bone disorders |
| 02/21/2007 | EP1753725A1 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics |
| 02/21/2007 | EP1753421A2 Arylsulfonamides and uses as hydroxysteroid dehydrogenase |
| 02/21/2007 | EP1511727B1 Aromatic sulfones and their medical use |
| 02/21/2007 | CN1918275A Alkoxylated polyol containing bleach activating terminating functional groups |
| 02/21/2007 | CN1918128A Fused ring 4-oxopyrimidine derivative |
| 02/21/2007 | CN1915995A S type 4-substituted hydroxy-pyranindolelidinyl compounds and its derivatives and production method |
| 02/21/2007 | CN1915964A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 02/20/2007 | US7179819 Benzyl -urea, -thiourea, or -guanidine derivatives that inhibit the binding of ligands to alpha 4 beta 1 integrin (VLA-4); for therapy and prophylaxis of pathologies associated with VLA-4 mediated cell adhesion, such as inflammatory and autoimmune diseases, and tumor metastasis |
| 02/15/2007 | WO2006103120A3 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
| 02/15/2007 | US20070037796 e.g. 7-Phenyl-isoquinoline-5-sulfonic acid {2-[3 -(4-nitrophenyl)-propylamino]-ethyl}-amide, dihydrochloride salt; antiviral, antineoplastic, anticarcinogenic agents; neoplasms |
| 02/15/2007 | US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | US20070037793 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/14/2007 | EP1752148A2 Substituted phenethylsulfones for the treatment of inflammatory, infectious, immunological or malignant disease |
| 02/14/2007 | EP1751111A1 Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
| 02/14/2007 | EP1750706A1 Dual small molecule inhibitors of cancer and angiogenesis |
| 02/14/2007 | EP1339701B1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 02/14/2007 | EP0999256B1 Compounds for organic el element and organic el element |
| 02/14/2007 | CN1913880A Method for treating ADAMTS-5-associated disease |
| 02/14/2007 | CN1300115C Method for synthesizing 1,2,3,4 ramification of tetrahydro-isoquinoline |